These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

251 related articles for article (PubMed ID: 28293972)

  • 21. Validation of the systemic lupus erythematosus activity questionnaire in a large observational cohort.
    Yazdany J; Yelin EH; Panopalis P; Trupin L; Julian L; Katz PP
    Arthritis Rheum; 2008 Jan; 59(1):136-43. PubMed ID: 18163398
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Drivers of cost and health-related quality of life in patients with systemic lupus erythematosus (SLE): a Swedish nationwide study based on patient reports.
    Bexelius C; Wachtmeister K; Skare P; Jönsson L; Vollenhoven Rv
    Lupus; 2013 Jul; 22(8):793-801. PubMed ID: 23761101
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Self-reported disease severity in women with systemic lupus erythematosus.
    Dima A; Caraiola S; Delcea C; Ionescu RA; Jurcut C; Badea C
    Rheumatol Int; 2019 Mar; 39(3):533-539. PubMed ID: 30415452
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Measures of adult systemic lupus erythematosus: updated version of British Isles Lupus Assessment Group (BILAG 2004), European Consensus Lupus Activity Measurements (ECLAM), Systemic Lupus Activity Measure, Revised (SLAM-R), Systemic Lupus Activity Questionnaire for Population Studies (SLAQ), Systemic Lupus Erythematosus Disease Activity Index 2000 (SLEDAI-2K), and Systemic Lupus International Collaborating Clinics/American College of Rheumatology Damage Index (SDI).
    Romero-Diaz J; Isenberg D; Ramsey-Goldman R
    Arthritis Care Res (Hoboken); 2011 Nov; 63 Suppl 11(0 11):S37-46. PubMed ID: 22588757
    [No Abstract]   [Full Text] [Related]  

  • 25. Reliability and validity of six systems for the clinical assessment of disease activity in systemic lupus erythematosus.
    Liang MH; Socher SA; Larson MG; Schur PH
    Arthritis Rheum; 1989 Sep; 32(9):1107-18. PubMed ID: 2775320
    [TBL] [Abstract][Full Text] [Related]  

  • 26. The effect of menopause on disease activity in systemic lupus erythematosus.
    Urowitz MB; Ibañez D; Jerome D; Gladman DD
    J Rheumatol; 2006 Nov; 33(11):2192-8. PubMed ID: 16981295
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Neuropsychiatric systemic lupus erythematosus: association with global disease activity.
    Morrison E; Carpentier S; Shaw E; Doucette S; Hanly JG
    Lupus; 2014 Apr; 23(4):370-7. PubMed ID: 24457602
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Sensitivity of the Systemic Lupus Erythematosus Disease Activity Index, British Isles Lupus Assessment Group Index, and Systemic Lupus Activity Measure in the evaluation of clinical change in childhood-onset systemic lupus erythematosus.
    Brunner HI; Feldman BM; Bombardier C; Silverman ED
    Arthritis Rheum; 1999 Jul; 42(7):1354-60. PubMed ID: 10403262
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Patient and Physician Perspectives of Systemic Lupus Erythematosus Flare: A Qualitative Study.
    Rogers JL; Clowse MEB; McKenna K; Starling S; Swezey T; Molokwu N; Corneli A; Pisetsky DS; Sun K; Criscione-Schreiber LG; Sadun RE; Maheswaranathan M; Burshell D; Doss J; Eudy AM
    J Rheumatol; 2024 May; 51(5):488-494. PubMed ID: 38101916
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Comparison of the systemic lupus erythematosus activity questionnaire and the systemic lupus erythematosus disease activity index in a black barbadian population.
    Quimby KR; Flower C; Hambleton IR; Landis RC; Hennis AJ
    Int J Rheumatol; 2013; 2013():875369. PubMed ID: 24282416
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Photoprotection awareness and practices among patients with systemic lupus erythematosus and its association with disease activity and severity.
    Abdul Kadir WD; Jamil A; Shaharir SS; Md Nor N; Abdul Gafor AH
    Lupus; 2018 Jul; 27(8):1287-1295. PubMed ID: 29665756
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Addition of constitutional symptoms to the SLEDAI-2K improves overall disease activity assessment: A pilot study.
    Anderson EW; Sansone M; Shah B; Kline M; Franchin G; Aranow C; Mackay M
    Lupus; 2024 Jul; 33(8):840-850. PubMed ID: 38664230
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Psychological distress and changes in the activity of systemic lupus erythematosus.
    Ward MM; Marx AS; Barry NN
    Rheumatology (Oxford); 2002 Feb; 41(2):184-8. PubMed ID: 11886968
    [TBL] [Abstract][Full Text] [Related]  

  • 34. The validity and reliability of Systemic Lupus Erythematosus Quality of Life Questionnaire (L-QoL) in a Turkish population.
    Duruöz MT; Unal C; Toprak CS; Sezer I; Yilmaz F; Ulutatar F; Atagündüz P; Baklacioglu HS
    Lupus; 2017 Dec; 26(14):1528-1533. PubMed ID: 28467289
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Neuropsychiatric events in systemic lupus erythematosus: attribution and clinical significance.
    Hanly JG; McCurdy G; Fougere L; Douglas JA; Thompson K
    J Rheumatol; 2004 Nov; 31(11):2156-62. PubMed ID: 15517627
    [TBL] [Abstract][Full Text] [Related]  

  • 36. TNF-α and plasma albumin as biomarkers of disease activity in systemic lupus erythematosus.
    Idborg H; Eketjäll S; Pettersson S; Gustafsson JT; Zickert A; Kvarnström M; Oke V; Jakobsson PJ; Gunnarsson I; Svenungsson E
    Lupus Sci Med; 2018; 5(1):e000260. PubMed ID: 29955370
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Two systemic lupus erythematosus (SLE) global disease activity indexes--the SLE Disease Activity Index and the Systemic Lupus Activity Measure--demonstrate different correlations with activation of peripheral blood CD4+ T cells.
    Daca A; Czuszyńska Z; Smoleńska Z; Zdrojewski Z; Witkowski JM; Bryl E
    Hum Immunol; 2011 Dec; 72(12):1160-7. PubMed ID: 21906646
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Sensitivity to change of 3 Systemic Lupus Erythematosus Disease Activity Indices: international validation.
    Gladman DD; Goldsmith CH; Urowitz MB; Bacon P; Bombardier C; Isenberg D; Kalunian K; Liang MH; Maddison P; Nived O
    J Rheumatol; 1994 Aug; 21(8):1468-71. PubMed ID: 7983648
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Clinical composite measures of disease activity and damage used to evaluate patients with systemic lupus erythematosus: A systematic literature review.
    Castrejón I; Rúa-Figueroa I; Rosario MP; Carmona L
    Reumatol Clin; 2014; 10(5):309-20. PubMed ID: 25022441
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Associations between physicians' global assessment of disease activity and patient-reported outcomes in patients with systemic lupus erythematosus: A longitudinal study.
    Louthrenoo W; Kasitanon N; Morand E; Kandane-Rathnayake R
    Lupus; 2021 Sep; 30(10):1586-1595. PubMed ID: 34192957
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 13.